Services Highlights

Allergy & Immunology

The only dedicated pediatric allergy and immunology program in the state, treating children with conditions ranging from asthma and other allergic diseases to rare primary or genetically determined immunodeficiency diseases.
Patients include the nation's largest population of infants and children born with Severe Combined Immunodeficiency Disorder (SCID), popularly known as the "bubble boy" syndrome. Duke physicians have dramatically improved their prognosis with early diagnosis and transplant of T cell-depleted parental bone marrow stem cells within the first few months of life.

Internationally recognized leadership and the nation's most extensive experience in pediatric cardiovascular surgery, specializing in complete repair of heart defects in infancy, with an overall hospital survival rate of 98 percent.
Specialized diagnostic facilities including the Pediatric Cardiac Catheterization Laboratory and the Pediatric Echocardiography Laboratory.
The state's most extensive and expert pediatric electrophysiology program and the region's only facility to perform esophageal EP studies and transvenous implantation of defibrillators and pacemakers in young children and infants.
Availability of lifesaving ECMO (extracorporeal membrane oxygenation) treatment to add oxygen and remove carbon dioxide from the blood of newborns suffering from persistent pulmonary hypertension, which occurs when constricted pulmonary arteries prevent a baby's heart from pumping blood to the lungs where it can become oxygenated.

State-of-the-art physiologic monitoring and leading-edge treatment modalities, including jet ventilation, high-frequency oscillatory ventilation, inhaled nitric oxide therapy and surgical correction of abdominal, thoracic and neurosurgical defects.
New, state-of-the-art pediatric emergency room, adjacent to Duke University Hospital's main emergency room, was recently opened. The new space is designed to better serve the needs of patients, caregivers, and staff by reducing congestion and improving flow.

Management of children with severe gastroesophageal reflux; infants with congenital malformations of the gastrointestinal tract; infants with intestinal, hepatic and abdominal tumors; and infants and children with obstructions of the bile ducts and pancreatic ducts.
Pediatric liver transplantation program that complements Duke's successful liver transplant program for adults.

Pediatric Bone Marrow Transplant Program performs the most transplants in the world, and is renowned for innovative clinical procedures pioneered at Duke.
The most comprehensive cord blood transplant program in the world.
Long-term childhood cancer survival clinic (one of the few such programs in the nation).
Comprehensive care for infants, children and adolescents with sickle cell disease.

Access to the most current neuro-imaging techniques available, including diffusion-weighted MRI and functional MRI; video EEG and ambulatory continuous EG monitoring; and a dedicated pediatric sleep disorders clinic.
Leading-edge interventions including genetic therapies for rare congenital neurologic disorders and highly precise stereotactic surgical techniques.
One of the few places in the United States to operate on infants with spina bifida in utero; also spearheading major studies of the genetic basis of spina bifida.

One of the few centers in the southeastern United States that specializes in treating congenital glaucoma.
Sophisticated diagnostic techniques that allow evaluation of sight in even very young infants.
Participation in multidisciplinary programs and clinics in retinoblastoma, juvenile rheumatoid arthritis (which can affect the eyes), Marfan syndrome and Down syndrome.

Expertise in the treatment and/or surgical reconstruction of airways that have been compromised by growths such as papillomas or cysts, or damaged by tracheostomies or chronic intubation.
Offers pediatric patients access to all cochlear implant devices currently available in the United States, whether under FDA trial or FDA-approved.

Duke's Craniofacial Program offers a multi-disciplinary approach to the management of cleft lip and palate and craniofacial deformities.
The Craniofacial Program sees 50-80 new pediatric craniofacial patients per year; 35-50 primary surgeries for craniosynostosis (a congenital condition impeding normal brain and skull growth) are performed per year.
Duke offers a comprehensive facial reanimation program to restore facial expression (particularly the ability to smile) to patients affected by permanent facial paralysis. Specialists from plastic surgery, speech therapy, and physical therapy provide a coordinated effort to patients, many of whom travel from a distance for treatment.
Duke's pediatric plastic surgeons have a special interest in treating functional and cosmetic problems for the nose (rhinoplasty). Such problems can be inherently cosmetic or may be the result of trauma or a congenital anomaly - such as a child who was born with a cleft.
The Interdisciplinary Craniofacial Imaging Research Lab is funded through industry and community-sponsored grants. It brings the most advanced quantitative and qualitative imaging technology to the clinical stage for treatment planning and objective analysis of outcome in craniofacial surgery. The lab has developed novel techniques and software to approach craniofacial morphology in the most comprehensive manner available.

Home to one of the best-equipped pediatric pulmonary function laboratories in the Southeast.
Aggressive management program in the treatment of cystic fibrosis (CF), incorporating an active clinical research program making the most current therapies available to the hundreds of children with CF seen each year at Duke Children's.

Sophisticated audiological testing, including newborn hearing screening, behavioral hearing evaluations and brainstem auditory-evoked response.
As the National Center for Communication Enhancement funded by the National Institute on Disability Rehabilitation & Research, Duke serves as a test bed for state-of-the-art augmentative and alternative communication technologies for children who cannot communicate due to profound congenital impairment or trauma.

Print | Share | Text: